Page last updated: 2024-09-04

cd 437 and Acne

cd 437 has been researched along with Acne in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arlabosse, JM; Bouix-Peter, C; Chambon, S; Chantalat, L; Daver, S; Dumais, L; Duvert, G; Feret, A; Ouvry, G; Pascau, J; Portal, T; Raffin, C; Rodeville, N; Soulet, C; Tabet, S; Talano, S; Thoreau, E1

Other Studies

1 other study(ies) available for cd 437 and Acne

ArticleYear
Structure-based design of Trifarotene (CD5789), a potent and selective RARĪ³ agonist for the treatment of acne.
    Bioorganic & medicinal chemistry letters, 2018, 06-01, Volume: 28, Issue:10

    Topics: Acne Vulgaris; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Structure-Activity Relationship

2018